These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11464482)

  • 1. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceruloplasminemia, an inherited disorder of iron metabolism.
    Miyajima H; Takahashi Y; Kono S
    Biometals; 2003 Mar; 16(1):205-13. PubMed ID: 12572680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG].
    Nagata M; Takiyama Y; Shimazaki H; Nakano I; Miyajima H
    No To Shinkei; 2004 Oct; 56(10):885-9. PubMed ID: 15609677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of ceruloplasmin deficiency which showed dementia, ataxia and iron deposition in the brain].
    Morita H; Inoue A; Yanagisawa N
    Rinsho Shinkeigaku; 1992 May; 32(5):483-7. PubMed ID: 1458725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The copper-iron connection: hereditary aceruloplasminemia.
    Nittis T; Gitlin JD
    Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruloplasmin in neurodegenerative diseases.
    Vassiliev V; Harris ZL; Zatta P
    Brain Res Brain Res Rev; 2005 Nov; 49(3):633-40. PubMed ID: 16269323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
    Harris ZL; Takahashi Y; Miyajima H; Serizawa M; MacGillivray RT; Gitlin JD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2539-43. PubMed ID: 7708681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
    Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurological presentation of ceruloplasmin gene mutations.
    McNeill A; Pandolfo M; Kuhn J; Shang H; Miyajima H
    Eur Neurol; 2008; 60(4):200-5. PubMed ID: 18667828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.